- Home
- NUAI vs SNSE Comparison
NUAI vs SNSE Comparison
Compare NUAI & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUAI
- SNSE
- Stock Information
- Founded
- NUAI N/A
- SNSE 2005
- Country
- NUAI United States
- SNSE United States
- Employees
- NUAI N/A
- SNSE N/A
- Industry
- NUAI Oil & Gas Production
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- NUAI Energy
- SNSE Health Care
- Exchange
- NUAI Nasdaq
- SNSE Nasdaq
- Market Cap
- NUAI 11.3M
- SNSE 10.8M
- IPO Year
- NUAI N/A
- SNSE 2021
- Fundamental
- Price
- NUAI $0.47
- SNSE $7.96
- Analyst Decision
- NUAI
- SNSE Strong Buy
- Analyst Count
- NUAI 0
- SNSE 4
- Target Price
- NUAI N/A
- SNSE $72.50
- AVG Volume (30 Days)
- NUAI 1.3M
- SNSE 33.6K
- Earning Date
- NUAI 08-14-2025
- SNSE 08-05-2025
- Dividend Yield
- NUAI N/A
- SNSE N/A
- EPS Growth
- NUAI N/A
- SNSE N/A
- EPS
- NUAI N/A
- SNSE N/A
- Revenue
- NUAI $718,761.00
- SNSE N/A
- Revenue This Year
- NUAI N/A
- SNSE N/A
- Revenue Next Year
- NUAI N/A
- SNSE N/A
- P/E Ratio
- NUAI N/A
- SNSE N/A
- Revenue Growth
- NUAI 14.80
- SNSE N/A
- 52 Week Low
- NUAI $0.38
- SNSE $5.00
- 52 Week High
- NUAI $12.29
- SNSE $17.40
- Technical
- Relative Strength Index (RSI)
- NUAI N/A
- SNSE 50.96
- Support Level
- NUAI N/A
- SNSE $7.21
- Resistance Level
- NUAI N/A
- SNSE $9.22
- Average True Range (ATR)
- NUAI 0.00
- SNSE 0.71
- MACD
- NUAI 0.00
- SNSE 0.01
- Stochastic Oscillator
- NUAI 0.00
- SNSE 37.59
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).